Menu
Back to User profile » Dr Jorgen Vestbo
Papers published by Dr Jorgen Vestbo:
Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study
Yorke J, Khan N, Garrow A, Tyson S, Singh D, Vestbo J, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2289-2299
Published Date: 15 September 2022
FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1135-1142
Published Date: 20 May 2020
Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
Langholm LL, Rønnow SR, Sand JMB, Leeming DJ, Tal-Singer R, Miller BE, Vestbo J, Karsdal MA, Manon-Jensen T
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:543-552
Published Date: 9 March 2020
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:853-861
Published Date: 16 April 2019
Automated oxygen control with O2matic® during admission with exacerbation of COPD
Hansen EF, Hove JD, Sandau Bech C, Stæhr Jensen JU, Kallemose T, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3997-4003
Published Date: 14 December 2018
What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs [Erratum]
Gayle A, Dickinson S, Morris K, Poole C, Mathioudakis AG, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3899-3900
Published Date: 5 December 2018
The Manchester Respiratory-related Sleep Symptoms scale for patients with COPD: development and validation
Khan N, Vestbo J, Garrow A, Karur P, Kolsum U, Tyson S, Singh D, Yorke J
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3885-3894
Published Date: 29 November 2018
What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs
Gayle A, Dickinson S, Morris K, Poole C, Mathioudakis AG, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3485-3492
Published Date: 23 October 2018
Validation of lung density indices by cardiac CT for quantification of lung emphysema
Ronit A, Kristensen T, Çolak Y, Kühl JT, Kalhauge A, Lange P, Nordestgaard BG, Vestbo J, Nielsen SD, Kofoed KF
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3321-3330
Published Date: 11 October 2018
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1125-1134
Published Date: 10 April 2018
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2917-2928
Published Date: 6 October 2017
Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease
Garrow AP, Yorke J, Khan N, Vestbo J, Singh D, Tyson S
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:293-307
Published Date: 9 February 2015